Atlas Trials

Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder

Clinical trial NCT04878250 · UNKNOWN

Trial details

NCT number
NCT04878250
Sponsor
Queen Mary University of London
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Transitional Cell CarcinomaBladder Cancer
Start date
2021-06-01
Primary completion
2023-07-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.